Cargando…

PF4 Immunoassays in Vaccine-Induced Thrombotic Thrombocytopenia

Detalles Bibliográficos
Autores principales:	Vayne, Caroline, Rollin, Jérôme, Gruel, Yves, Pouplard, Claire, Galinat, Hubert, Huet, Olivier, Mémier, Vincent, Geeraerts, Thomas, Marlu, Raphael, Pernod, Gilles, Mourey, Guillaume, Fournel, Alexandra, Cordonnier, Charlotte, Susen, Sophie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Massachusetts Medical Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174029/ https://www.ncbi.nlm.nih.gov/pubmed/34010527 http://dx.doi.org/10.1056/NEJMc2106383

Ejemplares similares

The Deglycosylated Form of 1E12, a Monoclonal Anti-PF4 IgG, Strongly Inhibits Antibody-Triggered Cellular Activation in Vaccine-Induced Thrombotic Thrombocytopenia, and Is a Potential New Treatment for Vιττ
por: Vayne, Caroline, et al.
Publicado: (2021)

Variable serotonin release assay pattern and specificity of PF4‐specific antibodies in HIT, and clinical relevance
por: Rollin, Jérôme, et al.
Publicado: (2022)

Hypotheses behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination
por: Douxfils, Jonathan, et al.
Publicado: (2021)

Fatal exacerbation of ChadOx1-nCoV-19-induced thrombotic thrombocytopenia syndrome after initial successful therapy with intravenous immunoglobulins - a rational for monitoring immunoglobulin G levels
por: Douxfils, Jonathan, et al.
Publicado: (2021)

The deglycosylated form of 1E12 inhibits platelet activation and prothrombotic effects induced by VITT antibodies
por: Vayne, Caroline, et al.
Publicado: (2022)

Pathophysiology and Diagnosis of Drug-Induced Immune Thrombocytopenia
por: Vayne, Caroline, et al.
Publicado: (2020)

Detection of Platelet-Activating Antibodies Associated with Heparin-Induced Thrombocytopenia
por: Tardy, Brigitte, et al.
Publicado: (2020)

Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Geeraerts, Thomas, et al.
Publicado: (2023)

Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient
por: Schönborn, Linda, et al.
Publicado: (2022)

The interaction between anti-PF4 antibodies and anticoagulants in vaccine-induced thrombotic thrombocytopenia
por: Singh, Anurag, et al.
Publicado: (2022)

Platelet-activating functional assay resolution in vaccine-induced immune thrombotic thrombocytopenia: differential alignment to PF4 ELISA platforms
por: Lee, Christine S.M., et al.
Publicado: (2023)

Comparison of Fibrin Monomers and D-dimers to predict thrombotic events in critically ill patients with COVID-19 pneumonia: A retrospective study
por: Godon, Alexandre, et al.
Publicado: (2021)

Thrombocytopenia in COVID-19 and vaccine-induced thrombotic thrombocytopenia
por: Geronikolou, Styliani A., et al.
Publicado: (2022)

Severe Thrombocytopenia, Thrombosis and Anti-PF4 Antibody after Pfizer-BioNTech COVID-19 mRNA Vaccine Booster—Is It Vaccine-Induced Immune Thrombotic Thrombocytopenia?
por: Ling, Victor W. T., et al.
Publicado: (2022)

Platelet-activating anti-PF4 antibodies mimic VITT antibodies in an unvaccinated patient with monoclonal gammopathy
por: Greinacher, Andreas, et al.
Publicado: (2021)

Oxford-AstraZeneca COVID-19 vaccine-induced cerebral venous thrombosis and thrombocytopaenia: A missed opportunity for a rapid return of experience
por: Geeraerts, Thomas, et al.
Publicado: (2021)

Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
por: Susen, Sophie, et al.
Publicado: (2020)

Vaccine-induced immune thrombotic thrombocytopenia
por: Klok, Frederikus A, et al.
Publicado: (2022)

Perspectives on vaccine induced thrombotic thrombocytopenia
por: Dotan, Arad, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia
por: Kanack, Adam J., et al.
Publicado: (2022)

Vaccine-induced immune thrombotic thrombocytopenia
por: Cines, Douglas B., et al.
Publicado: (2023)

Deep vein thrombosis as thrombotic sequelae of vaccine-induced thrombotic thrombocytopenia
por: Osei, Racheal, et al.
Publicado: (2023)

Genome-wide association study of platelet factor 4/heparin antibodies in heparin-induced thrombocytopenia
por: Giles, Jason B., et al.
Publicado: (2022)

Management of Pregnancy-Associated Thrombotic Thrombocytopenia Purpura
por: Fyfe-Brown, Ashley, et al.
Publicado: (2012)

An improbable and unusual case of thrombotic thrombocytopenia purpura
por: Patel, Jaymon, et al.
Publicado: (2016)

Hydroxychloroquine: Thrombotic thrombocytopenia purpura: case report
Publicado: (2020)

Vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Warkentin, Theodore E.
Publicado: (2022)

Recognizing Vaccine-Induced Immune Thrombotic Thrombocytopenia
por: Iba, Toshiaki, et al.
Publicado: (2021)

AZD-1222: Thrombotic thrombocytopenia: case report
Publicado: (2022)

The rollercoaster of vaccine-induced immune thrombotic thrombocytopenia
por: Cliff, Edward R Scheffer
Publicado: (2022)

Understanding vaccine‐induced thrombotic thrombocytopenia (VITT)
por: Dix, Caroline, et al.
Publicado: (2022)

Thrombotic Thrombocytopenia Masquerading As COVID-19 Infection
por: Desai, Krishna, et al.
Publicado: (2022)

AZD-1222: Immune thrombotic thrombocytopenia: case report
Publicado: (2021)

AZD-1222: Immune thrombotic thrombocytopenia: case report
Publicado: (2021)

Post-mortem findings in vaccine-induced thrombotic thrombocytopenia
por: Pomara, Cristoforo, et al.
Publicado: (2021)

AZD-1222: Immune thrombotic thrombocytopenia: case report
Publicado: (2021)

AZD-1222: Immune thrombotic thrombocytopenia: case report
Publicado: (2021)

Lessons from vaccine-induced immune thrombotic thrombocytopenia
por: Kelton, John Greenhow, et al.
Publicado: (2021)

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Greinacher, Andreas, et al.
Publicado: (2022)

Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)
por: Gabarin, Nadia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mfu2qsuifuun32n1ci20ns6di4